sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> grand mal seizure market

report

Grand Mal Seizure Market, by Drug Generation (First Generation, Second Generation, Third Generation), Drug Class (Barbiturates, Hydantoin, Cyclic Gaba Analogues, Phenyltriazine, Iminostilbenes, Aliphatic Carboxylic Acid, Benzodiazepines, Others), Surgery (Resective Surgery, Multiple Subpial Transection, Hemispherectomy, Corpus Callosotomy, Aliphatic Carboxylic Acid, Others), Diagnosis (Electroencephalogram (EEG), Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Blood Tests, Others), End-user – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC393 September 2017 100+ FREE 10% CUSTOMIZATION

Epilepsy is a assembly of neurological disorders that are being differentiated by brief or involuntary vigorous episodes of shaking of whole body or a part of body. The patient might experience disturbance or loss of movements and consciousness along with psychiatric or sensory disturbances. Grand mal seizures are a kind of generalized seizures that may affect the entire part of brain. It is normally caused by fatigue, hypertension, intense lighting, blood sugar level, neurotransmitter imbalances, lack of sleep, stress, rapid motion, anxiety, etc. The grand mal seizures comprises of two phases mainly clonic and tonic phase. The tonic phase is involves muscle twitching, loss of consciousness and this phase actually usually lasts for few seconds only. The clonic phase comprises of rapid muscle relaxation and contraction results in convulsions.

The report on the global Grand mal seizure market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • Growth of improved third generation drugs, growing patients screening, and escalating geriatric population as they are added vulnerable to epilepsy is boosting the market growth of grand mal seizure. The concentration of chief device manufacturers in several developed regions is also boosting the market growth of grand mal seizure market.
  • The global market for grand mal seizure is also restrained by poor efficiency and efficacy most of anti-epileptic drugs. It is normally caused by fatigue, hypertension, intense lighting, blood sugar level, neurotransmitter imbalances, lack of sleep, stress, rapid motion, anxiety, etc. Social stigma related with epilepsy particularly in several developed countries might hinder the market growth in the years to come.

Regionally, the global grand mal seizure market segmented into Europe, North America, Asia-Pacific, and the Rest of the World. Among these, the America region has been accounted for the considerable market share due to widespread usage of medications and huge healthcare expenditure. In addition, the speed uptake of latest technology and drugs in the region of US is driving the global market for grand mal seizures market. The concentration of chief device manufacturers in several developed regions is also boosting the market growth of grand mal seizure market. Europe region is the second huge market while the Asia Pacific region is projected to expand rapidly and India as well as China is likely to be dominant leader in the global grand mal seizure market in the years to come.  The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s grand mal seizure market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the grand mal seizure market by the following segments:

  • Grand Mal Seizure Market, by Drug Generation
    • First Generation
    • Second Generation
    • Third Generation
  • Grand Mal Seizure Market, by Drug Class
    • Barbiturates
    • Hydantoin
    • Cyclic Gaba Analogues
    • Phenyltriazine
    • Iminostilbenes
    • Aliphatic Carboxylic Acid
    • Benzodiazepines
    • Others
  • Grand Mal Seizure Market, by Surgery
    • Resective Surgery
    • Multiple Subpial Transection
    • Hemispherectomy
    • Corpus Callosotomy
    • Aliphatic Carboxylic Acid
    • Others
  • Grand Mal Seizure Market, by Diagnosis
    • Electroencephalogram (EEG)
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography (CT)
    • Blood Tests
    • Others
  • Grand Mal Seizure Market, by End Users
    • Hospitals
    • Neurological Centers
    • Academic and Research Centres
    • Others

KEY MARKET PLAYERS

Key players in the grand mal seizure market include:

  • Pfizer, Inc.
  • Johnson & Johnson Services, Inc.
  • UCB Celltech
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi
  • Shire Pharmaceuticals Limited
  • Teva Pharmaceutical Industries

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Heparin Market, by Product (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra Lower Molecular Weight Heparin(ULMWH)), Root of Administration (IV Injection, Subcutaneous Injection), Applications (Clinical Trials, Medical Devices, Venous Thromboembolism) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
  5. GRAND MAL SEIZURE MARKET, BY DRUG GENERATION
    1. Segment Share
    2. By Drug Generation
      1. First Generation
      2. Second Generation
      3. Third Generation
  6. GRAND MAL SEIZURE MARKET, BY DRUG CLASS
    1. Segment Share
    2. By Drug Class
      1. Barbiturates
      2. Hydantoin
      3. Cyclic Gaba Analogues
      4. Phenyltriazine
      5. Iminostilbenes
      6. Aliphatic Carboxylic Acid
      7. Benzodiazepines
      8. Others
  7. GRAND MAL SEIZURE MARKET, BY SURGERY
    1. Segment Share
    2. By Surgery
      1. Resective Surgery
      2. Multiple Subpial Transection
      3. Hemispherectomy
      4. Corpus Callosotomy
      5. Aliphatic Carboxylic Acid
      6. Others
  8. GRAND MAL SEIZURE MARKET, BY DIAGNOSIS
    1. Segment Share
    2. By Diagnosis
      1. Electroencephalogram (EEG)
      2. Magnetic Resonance Imaging (MRI)
      3. Computed Tomography (CT)
      4. Blood Tests
      5. Others
  9. GRAND MAL SEIZURE MARKET, BY END-USERS
    1. Segment Share
    2. By End-user
      1. Hospitals
      2. Neurological Centers
      3. Academic and Research Centres
      4. Others
  10. GRAND MAL SEIZURE MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Drug Generation
      3. By Drug Class
      4. By Surgery
      5. By Diagnosis
      6. By End-user
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Drug Class
      3. By Surgery
      4. By Diagnosis
      5. By End-user
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Drug Class
      3. By Surgery
      4. By Diagnosis
      5. By End-user
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Drug Class
      3. By Surgery
      4. By Diagnosis
      5. By End-user
  11. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
  12. KEY MARKET PLAYERS
    1. Pfizer, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Johnson & Johnson Services, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. UCB Celltech
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Abbott Laboratories
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. GlaxoSmithKline plc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Novartis AG
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Sanofi
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Shire Pharmaceuticals Limited
      1. Overview
      2. Key Strategies
      3. Key Developments
    9. Teva Pharmaceutical Industries
      1. Overview
      2. Key Strategies
      3. Key Developments
  13. SCALAR 360 DEGREE MARKET PERSPECTIVE
  14. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us